Lernik S. Hunanyan
Laboratory Of Structural Bioinformatics 123 H. Emin Str. 0051 Yerevan Armenia
Yerevan, ER, Armenia
Yerevan, ER, Armenia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Neurotropic potential and docking investigations of newly synthesized triazolopyridine and triazolothienopyridine derivatives.
Journal: RSC advances
Published: January 13, 2026
N-N-Substituted Piperazine, Cmp2, Improves Cognitive and Motor Functions in 5xFAD Mice.
Journal: International journal of molecular sciences
Published: April 04, 2025
Discovery of a novel piperazine derivative, cmp2: a selective TRPC6 activator suitable for treatment of synaptic deficiency in Alzheimer's disease hippocampal neurons.
Journal: Scientific reports
Published: June 24, 2024
Synthesis and Psychotropic Properties of Novel Condensed Triazines for Drug Discovery.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 26, 2024
Synthesis, evaluation of biological activity and SAR of new thioalkyl derivatives of pyridine.
Journal: Bioorganic chemistry
Published: March 16, 2024
Piperazine Derivative Stabilizes Actin Filaments in Primary Fibroblasts and Binds G-Actin In Silico.
Piperazine Derivative Stabilizes Actin Filaments in Primary Fibroblasts and Binds G-Actin In Silico.
Journal: Current issues in molecular biology
Published: September 14, 2022
Evaluation of Neurotropic Activity and Molecular Docking Study of New Derivatives of pyrano[4″,3″:4',5']pyrido[3',2':4,5]thieno[3,2-d]pyrimidines on the Basis of pyrano[3,4-c]pyridines.
Journal: Molecules (Basel, Switzerland)
Published: April 25, 2022
Computer-Based Drug Design of Positive Modulators of Store-Operated Calcium Channels to Prevent Synaptic Dysfunction in Alzheimer's Disease.
Journal: International journal of molecular sciences
Published: November 09, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026